Kingdon Capital Management, L.L.C. Genocea Biosciences, Inc. Transaction History

Kingdon Capital Management, L.L.C.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.01 - $1.38 $19,720 - $2.72 Million	-1,972,056 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$1.91 - $2.67 $2.41 Million - $3.37 Million	1,260,504 Added 177.15%	1,972,056 $4.77 Million
Q1 2020 May 15, 2020	SELL	$1.26 - $2.73 $27,087 - $58,689	-21,498 Reduced 2.93%	711,552 $1.22 Million
Q4 2019 Feb 14, 2020	BUY	$2.05 - $2.82 $95,997 - $132,054	46,828 Added 6.82%	733,050 $1.52 Million
Q3 2019 Nov 14, 2019	BUY	$2.9 - $4.07 $58,000 - $81,400	20,000 Added 3.0%	686,222 $1.99 Million
Q2 2019 Aug 14, 2019	BUY	$3.47 - $6.71 $2.31 Million - $4.47 Million	666,222 New	666,222 $2.61 Million

10K

Ticker GNCA
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,783,500
Description
Genocea Biosciences, Inc., a biopharmaceutical company, discovers and develops novel cancer immunotherapies. The company uses its proprietary discovery platform, ATLAS, which profiles each patient's CD4+ and CD8+ T cell immune responses to every target or antigen identified by next-generation sequencing of that patient's tumor. Its products incl...

Get notified when there are updates to the investment portfolio of Kingdon Capital Management, L.L.C., based on Form 13F filings with the SEC.

Stay updated on Kingdon Capital Management, L.L.C. with notifications on news.